Immunomedics Inc (IMMU.O)

IMMU.O on Consolidated Issue listed on NASDAQ Global Market

4.12USD
26 Nov 2014
Price Change (% chg)

-- (--)
Prev Close
$4.12
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
694,693
52-wk High
$6.17
52-wk Low
$3.04

IMMU.O

Chart for IMMU.O

About

Immunomedics, Inc. is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. The Company has developed a number of advanced technologies that allow the Company to create humanized antibodies that can be used either... (more)

Overall

Beta: 0.85
Market Cap (Mil.): $383.71
Shares Outstanding (Mil.): 93.13
Dividend: --
Yield (%): --

Financials

  IMMU.O Industry Sector
P/E (TTM): -- 219.87 38.74
EPS (TTM): -0.48 -- --
ROI: -127.79 -2.35 17.27
ROE: -133.38 -3.55 18.18
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks